AESI Background Rates Literature Review & Visualitzation for ASM
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
AESI Background Rates Literature Review & Visualitzation for ASM
应用场景：
创建时间：
2022-07-02
相关数据集
Factors associated with incidence rate of adverse events: Multiple logistic regression analysis.
Factors associated with incidence rate of adverse events: Multiple logistic regression analysis.
Figshare2023-06-22 更新110
Severe drug–drug interactions (DDIs) reported with high concurrence between Micromedex and Drugs.com.
Severe drug–drug interactions (DDIs) reported with high concurrence between Micromedex and Drugs.com.
Figshare2023-11-16 更新60
Supplementary Material for: Evaluation of safety of elacestrant in patients with breast cancer: Insights from FDA adverse event reporting system database analysis
Introduction: This study aims to evaluate the safety profile of elacestrant in real-world settings using data from the FDA adverse event reporting system (FAERS) database, offering insights to inform
DataCite Commons2025-06-04 更新40
Disproportionality analysis of the safety profile of rufinamide in the real world: an evaluation of the FDA adverse event reporting system database
The antiepileptic drug rufinamide (RUF), was recently introduced to alleviate seizures in patients with Lennox-Gastaut syndrome (LGS). However, little is known about its adverse reactions. The objecti
DataCite Commons2025-12-05 更新70
Adverse events at the end of Phase 1 and 2 respectively, by MedDRA SOC.
Adverse events at the end of Phase 1 and 2 respectively, by MedDRA SOC.
Figshare2020-10-02 更新50
